Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells.

Peired AJ, Antonelli G, Angelotti ML, Allinovi M, Guzzi F, Sisti A, Semeraro R, Conte C, Mazzinghi B, Nardi S, Melica ME, De Chiara L, Lazzeri E, Lasagni L, Lottini T, Landini S, Giglio S, Mari A, Di Maida F, Antonelli A, Porpiglia F, Schiavina R, Ficarra V, Facchiano D, Gacci M, Serni S, Carini M, Netto GJ, Roperto RM, Magi A, Christiansen CF, Rotondi M, Liapis H, Anders HJ, Minervini A, Raspollini MR, Romagnani P.

Sci Transl Med. 2020 Mar 25;12(536). pii: eaaw6003. doi: 10.1126/scitranslmed.aaw6003.

PMID:
32213630
2.

Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K.

Petroni G, Bagni G, Iorio J, Duranti C, Lottini T, Stefanini M, Kragol G, Becchetti A, Arcangeli A.

Cell Death Dis. 2020 Mar 2;11(3):161. doi: 10.1038/s41419-020-2349-8.

3.

The hERG1 Potassium Channel Behaves As Prognostic Factor In Gastric Dysplasia Endoscopic Samples.

Lastraioli E, Romoli MR, Iorio J, Lottini T, Chiudinelli M, Bencivenga M, Vindigni C, Tomezzoli A, De Manzoni G, Compagnoni B, Manzi I, Messerini L, Saragoni L, Arcangeli A; Gruppo Italiano di Ricerca Cancro Gastrico (GIRCG).

Onco Targets Ther. 2019 Nov 7;12:9377-9384. doi: 10.2147/OTT.S226257. eCollection 2019.

4.

Generation and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging.

Duranti C, Carraresi L, Sette A, Stefanini M, Lottini T, Crescioli S, Crociani O, Iamele L, De Jonge H, Gherardi E, Arcangeli A.

Oncotarget. 2018 Oct 9;9(79):34972-34989. doi: 10.18632/oncotarget.26200. eCollection 2018 Oct 9.

5.

LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer.

Noci I, Sorbi F, Mannini L, Projetto E, Pillozzi S, Ghizzoni V, Lottini T, Moncini D, Baroni G, Mungai F, Arcangeli A, Fambrini M.

Front Oncol. 2016 Aug 25;6:190. doi: 10.3389/fonc.2016.00190. eCollection 2016.

6.

hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance.

Lastraioli E, Lottini T, Iorio J, Freschi G, Fazi M, Duranti C, Carraresi L, Messerini L, Taddei A, Ringressi MN, Salemme M, Villanacci V, Vindigni C, Tomezzoli A, La Mendola R, Bencivenga M, Compagnoni B, Chiudinelli M, Saragoni L, Manzi I, De Manzoni G, Bechi P, Boni L, Arcangeli A.

Oncotarget. 2016 Sep 13;7(37):59535-59547. doi: 10.18632/oncotarget.11149.

7.

hERG1 Potassium Channels: Novel Biomarkers in Human Solid Cancers.

Lastraioli E, Lottini T, Bencini L, Bernini M, Arcangeli A.

Biomed Res Int. 2015;2015:896432. doi: 10.1155/2015/896432. Epub 2015 Aug 3. Review.

Supplemental Content

Loading ...
Support Center